FRSX vs. IDN, AIXI, CCLD, BMR, LGCL, VRME, DUOT, RTC, MNDO, and WAVS
Should you be buying Foresight Autonomous stock or one of its competitors? The main competitors of Foresight Autonomous include Intellicheck (IDN), Xiao-I (AIXI), CareCloud (CCLD), Beamr Imaging (BMR), Lucas GC (LGCL), VerifyMe (VRME), Duos Technologies Group (DUOT), Baijiayun Group (RTC), MIND C.T.I. (MNDO), and Western Acquisition Ventures (WAVS). These companies are all part of the "computer software" industry.
Foresight Autonomous vs.
Foresight Autonomous (NASDAQ:FRSX) and Intellicheck (NYSE:IDN) are both small-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, community ranking, institutional ownership, profitability and media sentiment.
In the previous week, Foresight Autonomous had 6 more articles in the media than Intellicheck. MarketBeat recorded 7 mentions for Foresight Autonomous and 1 mentions for Intellicheck. Foresight Autonomous' average media sentiment score of 0.21 beat Intellicheck's score of 0.00 indicating that Foresight Autonomous is being referred to more favorably in the media.
Intellicheck has a net margin of -3.37% compared to Foresight Autonomous' net margin of -2,450.11%. Intellicheck's return on equity of -1.59% beat Foresight Autonomous' return on equity.
Intellicheck has a consensus target price of $3.33, suggesting a potential upside of 16.96%. Given Intellicheck's stronger consensus rating and higher possible upside, analysts clearly believe Intellicheck is more favorable than Foresight Autonomous.
23.5% of Foresight Autonomous shares are held by institutional investors. Comparatively, 42.8% of Intellicheck shares are held by institutional investors. 10.6% of Foresight Autonomous shares are held by company insiders. Comparatively, 8.9% of Intellicheck shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Foresight Autonomous has a beta of 1.43, meaning that its share price is 43% more volatile than the S&P 500. Comparatively, Intellicheck has a beta of 1.81, meaning that its share price is 81% more volatile than the S&P 500.
Intellicheck has higher revenue and earnings than Foresight Autonomous. Intellicheck is trading at a lower price-to-earnings ratio than Foresight Autonomous, indicating that it is currently the more affordable of the two stocks.
Foresight Autonomous received 128 more outperform votes than Intellicheck when rated by MarketBeat users. Likewise, 69.16% of users gave Foresight Autonomous an outperform vote while only 51.79% of users gave Intellicheck an outperform vote.
Summary
Intellicheck beats Foresight Autonomous on 11 of the 18 factors compared between the two stocks.
Get Foresight Autonomous News Delivered to You Automatically
Sign up to receive the latest news and ratings for FRSX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Foresight Autonomous Competitors List
Related Companies and Tools
This page (NASDAQ:FRSX) was last updated on 1/21/2025 by MarketBeat.com Staff
